23 results
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
27 Apr 23
Report of Foreign Private Issuer
7:02am
Improved memory retention and functional recovery
Accelerated hematoma resolution at 7 days after ICH
Reduced neuronal cell death at 7 days after ICH
6-K
EX-10.1
TLSA
Tiziana Life Sciences Ltd
4 Aug 20
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
4:26pm
or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent
6-K
EX-1.1
ebtr2tv64
14 Apr 20
Current report (foreign)
8:46am
F-1/A
rdtraqx54ddmy
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
qqaqb8oj
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
F-1
x2cn5u0uav1 olg26gz
5 Aug 19
Registration statement (foreign)
4:28pm
F-1
EX-1.1
ps3y1cxu1gcfz 64s
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
EX-1.1
rwubao wj7jl2p6uah
17 Jul 19
Draft registration statement
12:00am
DRS
cxer mk5cvtqlh1j
17 Jul 19
Draft registration statement
12:00am
20-F
6iq uiqxb
4 Apr 19
Annual report (foreign)
6:07am
424B4
ihyv3ek9tfrdb
21 Nov 18
Prospectus supplement with pricing info
6:10am
POS AM
b96eqz509xslu06f
14 Nov 18
Prospectus update (post-effective amendment)
12:00am
F-1/A
6b6i5tj bjy
30 Oct 18
Registration statement (foreign) (amended)
12:00am
F-6/A
EX-99
yp8wi un75e7
29 Oct 18
Registration for ADRs (foreign) (amended)
5:16pm
F-1/A
k1by7hr9acrgr7
23 Oct 18
Registration statement (foreign) (amended)
1:04pm
F-1/A
q0xnznktr3
17 Oct 18
Registration statement (foreign) (amended)
8:40pm